Andrographolide: A New Plant‐Derived Antineoplastic Entity on Horizon
Open Access
- 1 January 2011
- journal article
- research article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2011 (1) , 815390
Abstract
Plant‐derived natural products occupy an important position in the area of cancer chemotherapy. Molecules such as vincristine, vinblastine, paclitaxel, camptothecin derivatives, epipodophyllotoxin, and so forth, are invaluable contributions of nature to modern medicine. However, the quest to find out novel therapeutic compounds for cancer treatment and management is a never‐ending venture; and diverse plant species are persistently being studied for identification of prospective anticancer agents. In this regard, Andrographis paniculata Nees, a well‐known plant of Indian and Chinese traditional system of medicines, has drawn attention of researchers in recent times. Andrographolide, the principal bioactive chemical constituent of the plant has shown credible anticancer potential in various investigations around the globe. In vitro studies demonstrate the capability of the compound of inducing cell‐cycle arrest and apoptosis in a variety of cancer cells at different concentrations. Andrographolide also shows potent immunomodulatory and anti‐angiogenic activities in tumorous tissues. Synthetic analogues of the compound have also been created and analyzed, which have also shown similar activities. Although it is too early to predict its future in cancer chemotherapy, the prologue strongly recommends further research on this molecule to assess its potential as a prospective anticancer agent.Keywords
This publication has 84 references indexed in Scilit:
- Mediation of Endogenousβ‐Endorphin in the Plasma Glucose‐Lowering Action of Herbal Products Observed in Type 1‐Like Diabetic RatsEvidence-Based Complementary and Alternative Medicine, 2010
- Benzylidene derivatives of andrographolide inhibit growth of breast and colon cancer cells in vitro by inducing G1 arrest and apoptosisBritish Journal of Pharmacology, 2008
- Inhibition of cell-cycle progression in human colorectal carcinoma Lovo cells by andrographolideChemico-Biological Interactions, 2008
- Therapeutic Potential of Plants as Anti‐Microbials for Drug DiscoveryEvidence-Based Complementary and Alternative Medicine, 2008
- Regulatory T Cells, a Potent Immunoregulatory Target for CAM Researchers: Modulating Tumor Immunity, Autoimmunity and Alloreactive Immunity (III)Evidence-Based Complementary and Alternative Medicine, 2006
- Deficient Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Death Receptor Transport to the Cell Surface in Human Colon Cancer Cells Selected for Resistance to TRAIL-induced ApoptosisJournal of Biological Chemistry, 2004
- Inflammation and cancerNature, 2002
- Pharmacokinetic and oral bioavailability of andrographolide from Andrographis paniculata fixed combination Kan Jang in rats and humanPhytomedicine, 2000
- Cell Differentiation-Inducing Diterpenes from Andrographis paniculata NEES.Chemical and Pharmaceutical Bulletin, 1994
- Andrographolide: an X-ray crystallographic analysisJournal of Chemical Crystallography, 1982